Could Versartis recover after today’s big decline?
A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.
Friday turned out to be a nightmare for Versartis Inc (NASDAQ:VSAR) investors, after the drug maker reported negative Phase 3 VELOCITY data in …